Skip to content
Screener

Sarepta Therapeutics, Inc. SRPT Manufacturing Costs

Manufacturing Costs at other companies

Luxfer Holdings logo
Luxfer HoldingsLXFR
$8.6M+3.6%
Luxfer Holdings logo
Luxfer HoldingsLXFR
$200K-33.3%
Flex Ltd. logo
Flex Ltd.FLEX
$695M+9.1%
Flex Ltd. logo
Flex Ltd.FLEX
$758M+10.7%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$9.09M-39.2%
Nuvectis Pharma, Inc. logo
Nuvectis Pharma, Inc.NVCT
$829K+74.2%

Segments

By segment

See full
All Other Segments$1.84M-97.7%

Other financials

Income statement

See full
Revenue$401.3M-34.3%
Operating income$13.3M-88.5%
Net income-$4.9M-102%
EPS (diluted)-$0.05-103%

Balance sheet

See full
Cash & equivalents$571.1M+11.9%
Total debt$198.2M-7.6%
Total equity$1.5B+8.8%
Total assets$3.2B-13.4%

Cash flow

See full
Operating cash flow-$202.7M+65.3%
CapEx$555.0K-98.3%
Free cash flow-$204.8M+67.3%

Valuation

See full
Market cap$1.77B+10.9%
Enterprise value$1.4B+7.5%
P/S0.9×—

Profitability

See full
Operating margin-50.8%-1.6pp
Net margin-6.9%—
FCF margin-28.7%-9.2pp

Returns & leverage

See full
Return on equity-9.3%+2,662pp
Debt / equity0.1×0.0×
Current ratio4.4×+1.5×